SCHEDULE: Vanguard Group Boosts Medtronic Stake to 10.21%

The Vanguard Group has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 10.21% in Medtronic PLC common stock.

Summary

• The Vanguard Group beneficially owns 130,949,305 shares of Medtronic PLC common stock.
• This ownership represents 10.21% of the class of securities.
• Vanguard holds sole dispositive power over 118,346,690 shares.
• Vanguard holds shared dispositive power over 12,602,615 shares.
• Vanguard holds shared voting power over 7,668,852 shares.
• Vanguard holds no sole voting power over the shares.
• This document is Amendment No. 9 to the Schedule 13G filing.

Sentiment

Score: 5

Explanation: This is a routine beneficial ownership disclosure (Schedule 13G Amendment No. 9) by a large institutional investor, The Vanguard Group. It reflects passive investment holdings and does not contain information that would significantly alter the sentiment towards the issuer's operational or financial performance.

Future Outlook

NA

Management Comments

• The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• No one other person's interest in the securities reported herein is more than 5%.
• The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

This filing reflects a routine disclosure by a major institutional asset manager, The Vanguard Group, regarding its passive investment holdings in Medtronic PLC. Such filings are common for large index fund providers and typically do not indicate a change in investment strategy specific to the issuer, but rather reflect portfolio adjustments based on index rebalancing or client flows.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming a large, passive investment presence.

Key Dates

Keywords

Medtronic PLC, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, MDT